1115 related articles for article (PubMed ID: 19188680)
1. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
Reck M; von Pawel J; Zatloukal P; Ramlau R; Gorbounova V; Hirsh V; Leighl N; Mezger J; Archer V; Moore N; Manegold C
J Clin Oncol; 2009 Mar; 27(8):1227-34. PubMed ID: 19188680
[TBL] [
